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Infection in the Nasal Tip Caused by Acellular Dermal Matrix
She complained about her low take-off point, which was apparent in profile view, and wanted slight tip projection. She refused additional cartilage harvesting from ears or ribs but consented to the use of homologous tissue, including acellular dermal matrix, for her dorsum and tip. Septoturbinoplasty was performed, and only a very small amount of septal cartilage could be harvested. It was used as both the columellar strut and the alar rim graft. Nasal dorsum and tip were augmented with acellular dermal matrix. Three months postoperatively, she experienced a few episodes of edema and redness on her nasal tip, followed by pus exudation from the nasal skin. Six months postoperatively, she underwent revision rhinoplasty for removal of inflamed grafts, and onlay tip graft with homologous rib cartilage was performed. Nasal dorsum or tip grafts are an integral part of Asian rhinoplasty. Autogenous tissue is the gold standard for grafting materials. However, the limited availability of autogenous tissue and the preference of patients and surgeons for artificial surgical implants make Asian rhinoplasty challenging. Unavailability of autogenous cartilage and patient refusal of artificial implants led to the use of acellular dermal matrix (ADM) in the nasal dorsum and tip for this case. This is the first report of postoperative complication because of infection rather than absorption after ADM use. 
BRIEF REVIEW OF THE LITERATURE
The use of ADM in head and neck reconstruction has been reported since the 1990s.
1 ADM provides collagen matrix for host tissue ingrowth, and histological analysis has revealed no evidence of inflammatory cell infiltration or cell-mediated immune response with ADM use. 2 The material provides a matrix for eventual replacement, making displacement, exposure, and infection rare. 3 In an animal study, 38.8% of the ADM was present at 12 weeks, but it maintained the central graft structure and then started to change peripherally into neocollagen. 4 An additional advantage is that it maintains its structure and contour for as long as it takes the implant to be completely replaced by the newly synthesized collagen. 4 Jackson et al 5 reported the use of ADM for palpable or visible bony irregularities on the nasal dorsum as a result either of previous rhinoplasties or of trauma. No infection was discovered in the 6-to 24-month postoperative period in 15 patients. 5 Gryskiewicz et al 3 reported 2-year outcome of the use of ADM for dorsal augmentation, tip grafting, or camouflage over autogenous grafts in 20 patients. Forty-five percent of the patients showed partial graft resorption. 3 However, no infection was reported. No cases of infection, seroma formation, septal perforation, significant resorption, or extrusion related to ADM placement during rhinoplasty and septoplasty were reported among 51 patients. 6 A systematic review revealed that ADM use was not associated with infection. 1 Here, I report a recently encountered case of infection in the nasal tip associated with ADM use. 
